Search Results for 'multiple sclerosis'

20 results found.

Vitamin D supplements to protect baby’s bone development

Parents of all babies, from birth to 12 months, are being advised to give their infants a daily vitamin D supplement to protect their growing bones. This advice comes to parents and guardians from the Health Service Executive, the Food Safety Authority of Ireland, and the Department of Health and Children.

Summer barbecue for MS

On Sunday July 18 the gardens of Hotel Westport will once again be the venue for the annual Multiple Sclerosis Summer barbecue.

Summer barbecue for MS

On Sunday July 18 the gardens of Hotel Westport will once again be the venue for the annual Multiple Sclerosis Summer barbecue.

Hollister ULC to create a number of high tech positions in R&D and engineering

A Galway-based recruitment agency is handling a campaign by Hollister ULC to recruit a number of key research and development, engineering, and manufacturing positions for its facility in Mayo.

Tysabri can improve life quality, says Elan

image preview

Athlone-based Elan has claimed that a post-hoc analysis showed that its controversial multiple sclerosis drug Tysabri increases the probability of achieving sustained improvement in physical disability over two years when compared to a placebo.

Orthoscopic clinic opens in Knocknacarra

Richard Hughes opticians has opened an orthoscopic clinic at his practice at Seacrest, Knocknacrra.

Elan future under review

A possible merger or sale are among the options currently being examined by Elan in order to secure the future of the company.

Good news for Elan as study illustrates Tysabri MS success

image preview

Athlone-based drug developer and its US partner, Biogen Idec, last evening hailed success from a study into the effects of their MS drug, Tysabri in repairing damage to the myelin sheath, a key cause of MS.

Ceart Healthcare suffers cutbacks in service

image preview

Ceart Healthcare centre in Callan is suffering from lack of funding leading to the therapy centre remaining closed on Fridays.

Elan’s Tysabri lowers Crohn’s hospitalisations

Athlone-based pharmaceutical company, Elan, and its US partner Biogen have announced that their drug Tysabri has been proven to significantly reduce the rate of hospitalisation of patients with moderate-to-severe Crohn’s disease.

  • 1
  • 2 (current)
 

Page generated in 0.0449 seconds.